Vexal XR 37.5 mg – 14 Extended Release Capsules

Description

Vexal XR 37.5 mg contains venlafaxine, an SNRI antidepressant prescription medication used in the management of depression and selected anxiety disorders under medical supervision. It works by helping rebalance serotonin and norepinephrine neurotransmitters involved in mood regulation and anxiety response.

Its extended-release XR formulation provides gradual medication release throughout the day, helping maintain stable therapeutic levels with convenient once-daily dosing. This lower strength may be used as an initial titration dose or dose-adjustment step depending on physician guidance.

Key Benefits

• Contains Venlafaxine 37.5 mg
• Extended-release XR once-daily formula
• SNRI antidepressant medication
• Supports depression management
• Used in selected anxiety disorders
• Suitable for dose titration plans
• Sustained therapeutic release

How to Use

• Use exactly as prescribed
• Usually taken once daily
• Best taken with food
• Swallow capsule whole
• Do not crush, chew, or open
• Do not discontinue abruptly

Indications

• Major depressive disorder
• Generalized anxiety disorder
• Social anxiety disorder
• Panic disorder

Warnings

• Prescription-only medicine
• Monitor blood pressure during treatment
• Risk of serotonin syndrome with interacting medicines
• Withdrawal symptoms may occur if stopped suddenly
• Use cautiously in cardiovascular, kidney, or liver disease
• May cause dizziness, insomnia, or drowsiness
• Pregnancy and breastfeeding require physician guidance

Side Effects

• Nausea
• Headache
• Dry mouth
• Dizziness
• Sweating
• Sleep disturbances
• Appetite changes
• Constipation
• Sexual side effects

Product Details

• Form Extended-release capsules
• Strength 37.5 mg
• Pack Size 14 capsules
• Active Ingredient Venlafaxine
• Category SNRI antidepressant
• Prescription required